Diabetes in Argentina: Cost and management of diabetes and its complications and challenges for health policy

Globalization and Health

Volumn 9, Issue 1, 2013, Pages

  Caporale, Joaquín E ^a   Elgart, Jorge F ^a   Gagliardino, Juan J ^a  

^a University of La Plata CONICET   (Argentina)

Author keywords

Argentina; Costs; Diabetes; Diabetes management; Prevalence

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

COST; DIABETES; DISEASE PREVALENCE; HEALTH CARE; HEALTH POLICY; MORTALITY; POLICY IMPLEMENTATION; QUALITY OF LIFE;

ACUTE HEART INFARCTION; AMPUTATION; ARGENTINA; ARTICLE; BLINDNESS; CEREBROVASCULAR ACCIDENT; CLAUDICATION; COST CONTROL; DIABETES EDUCATION; DIABETES MELLITUS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DISEASE CONTROL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITALIZATION COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MORTALITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; SOCIOECONOMICS; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; HEALTH EDUCATION; HOSPITALIZATION; REVIEW;

ARGENTINA;

ARGENTINA; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; HEALTH CARE COSTS; HEALTH EDUCATION; HEALTH POLICY; HOSPITALIZATION; HUMANS; PREVALENCE;

EID: 84886388967     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/1744-8603-9-54     Document Type: Article

References (46)

1. Ferrante D, Linetzky B, Konfino J, King A, Virgolini M, Laspiur S. Encuesta Nacional de Factores de Riesgo 2009: Evolución de la epidemia de enfermedades crónicas no trasmisibles en Argentina. Estudio de Corte Transversal. Rev Argent Salud Publica 2011, 2:34-41.
2. Araújo GTB, Caporale JE, Stefani S, Pinto D, Caso A. Is equity of access to health care achievable in Latin America?. Value Health 2011, 14:S8-S12. 10.1016/j.jval.2011.05.037, 21839905.
3. Dirección de Información Parlamentaria. Congreso de la Nación Programa Médico Obligatorio - Legislación Nacional vigente http://www1.hcdn.gov.ar/dependencias/dip/documentos/RL.109.05.00-1.pdf, Dirección de Información Parlamentaria. Congreso de la Nación.
4. Hernández RE, Cardonnet L, Libman C, Gagliardino JJ. Prevalence of diabetes and obesity in an urban population of Argentina. Diabetes Res Clin Practice 1987, 3:277-283.
5. Ministerio de Salud de la Nación Vigilancia de Enfermedades No Transmisibles 2004, Buenos Aires, Argentina: Boletín Epidemiológico Periódico (Edición Especial), Ministerio de Salud de la Nación.
6. Dirección de Estadísticas e Información de Salud. Ministerio de Salud Evolución de la mortalidad según causas. Argentina - Período 1997-2006 http://www.deis.gov.ar/publicaciones/Archivos/Serie12nro6.pdf, Dirección de Estadísticas e Información de Salud. Ministerio de Salud.
7. Dirección de Estadísticas e Información de Salud. Ministerio de Salud Agrupamiento de causas de mortalidad por division politico territorial de residencia, edad y sexo. Argentina - año 2009 http://www.deis.gov.ar/publicaciones/Archivos/Boletin131.pdf, Dirección de Estadísticas e Información de Salud. Ministerio de Salud.
8. Murray CJM, Lopez AD. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2016 1996, Cambridge: Harvard University Press.
9. Caporale JE, Gagliardino JJ. Costos de atención de la diabetes tipo 2 en Argentina. Un análisis de sensibilidad probabilístico. Rev Soc Argent de Diabetes 2010, 44:349-357.
10. Elgart J, Caporale JE, Pfirter G, González L, Siri F, Gagliardino JJ. Estimación del costo asociado a la pérdida de productividad por mortalidad atribuible a la diabetes en Argentina [abstract]. Value in Health 2009, 12(7):A505.
11. Borruel MA, Mas IP, Borruel GD. Estudio de carga de enfermedad 2010, Argentina. Buenos Aires: Ministerio de Salud de la Nación, http://www.msal.gov.ar/fesp/images/stories/recursos-de-comunicacion/publicaciones/Estudio_de_carga_FESP_Imprenta.pdf.
12. Gagliardino JJ, de la Hera M, Siri F, Grupo de Investigación de la Red QUALIDIAB Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Salud Pública/Pan Am J Public Health 2001, 10:309-317. Grupo de Investigación de la Red QUALIDIAB.
13. Gagliardino JJ, de la Hera M, Siri F. Evaluación preliminar de la calidad de atención de personas con diabetes en Argentina. Rev Soc Argent de Diabetes 2001, 35:121-133.
14. Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, Ramachandran A, Aschner P, IDMPS Investigators Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009, 32:227-233. 2628684, 19033410, IDMPS Investigators.
15. Ringborg A, Cropet C, Jonsson B, Gagliardino JJ, Ramachandran A, Lindgren P. Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). Int J Clin Pract 2009, 63:997-1007. 10.1111/j.1742-1241.2009.02098.x, 19570117.
16. Luongo AM, López González E, Garcia AB, González CD, Ruiz ML, Burlando G, Ruiz M. Evaluación del tratamiento de la diabetes tipo 2 realizado por especialistas en Argentina. Revista ALAD 2011, 1:78-87.
17. Ministerio de Salud y Acción Social Programa Nacional de Diabetes (PRONADIA) http://www.msal.gov.ar/ent/images/stories/programas/pdf/resolucion-301-99-probacion-pronadia.pdf, Ministerio de Salud y Acción Social.
18. Gagliardino JJ. Hyperglycemia and chronic complications in type 2 diabetes: the challenge of its prevention within the framework of cost-effectiveness and health equity. Dialogue 1998 Third Quarter 5-8.
19. Gagliardino JJ, Martella A, Etchegoyen GS, Caporale JE, Guidi ML, Olivera EM, González C. Hospitalization and re-hospitalization of people with and without diabetes in La Plata, Argentina: comparison of their clinical characteristics and costs. Diab Res Clin Pract 2004, 65:51-59.
20. Gagliardino JJ, Olivera E, Etchegoyen GS, Guidi ML, Caporale JE, Martella A, de la Hera M, Siri F, Bonelli P. PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diab Res Clin Pract 2006, 72:284-291.
21. Caporale JE, Calvo H, Gagliardino JJ. Costos de atención en personas con diabetes previos y posteriores a su hospitalización. Rev Panam Salud Publica 2006, 20:361-368. 10.1590/S1020-49892006001100001, 17341326.
22. Gagliardino JJ, Kleinebreil L, Colagiuri S, Flack J, Caporale JE, Siri F, Clark C. Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America. Diabetes Res Clin Pract 2010, 88:7-13. 10.1016/j.diabres.2009.12.024, 20153542.
23. Gagliardino JJ, Werneke U, Olivera EM, Assad D, Regueiro F, Díaz R, Pollola J, Paolasso E. Characteristics, clinical course and in-hospital mortality of non-insulin-dependent diabetic and nondiabetic patients with acute myocardial infarction in Argentina. J Diab Comp 1997, 11:163.
24. Gagliardino JJ, Jadzinsky M, Cédola NV, Alvariñas J, Hernández RE, Sederay M, Sinay I, Clark C. Diabetes y otros factores de riesgo cardiovascular. Prevención y tratamiento 2005, La PLata, Argentina: Magenta.
25. Gagliardino JJ, Olivera EM, Etchegoyen GS, González C, Guidi ML. Evaluación y costos del proceso de atención de pacientes diabéticos. Medicina 2000, 60:880-888.
26. Caporale JE, Elgart J, Pfirter G, Martínez P, Viñes G, Insúa JT, Gagliardino JJ. Hospitalization costs for heart failure in people with type 2 diabetes: cost-effectiveness of its prevention measured by simulated preventive treatment. Value Health 2011, 14:S20-S23. 10.1016/j.jval.2011.05.018, 21839892.
27. Caporale JE, Elgart JF, Gagliardino JJ. The cost of diabetes care programs for type 2 diabetes in Argentina: a probabilistic sensitivity analysis. Primary Health Care: Open Access 2011, 1:105. doi:10.4172/phcoa.1000105.
28. Olivera E, Pérez Duhalde E, Gagliardino JJ. Costs of temporary and permanent disability induced by diabetes. Diabetes Care 1991, 14:593-596. 10.2337/diacare.14.7.593, 1833169.
29. Gagliardino JJ, Arrechea V, Assad D, Gagliardino GG, González L, Lucero S, Rizzuti L, Zufriategui Z, Clark C. Type 2 diabetes patients educated by other patients perform at least as well as patients trained by professionals. Diabetes Metab Res Rev 2013, 29(2):152-160. 10.1002/dmrr.2368, 23166062.
30. Gagliardino JJ, Etchegoyen G. A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 2001, 24:1001-1007. 10.2337/diacare.24.6.1001, 11375360.
31. Gagliardino JJ, Lapertosa S, Pfirter G, Villagra M, Caporale JE, Gonzalez CD, Elgart J, González L, Cernadas C, Rucci E, Clark C, PRODIACOR Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med 2013, doi:10.1111/dme.12230. Epub ahead of print, PRODIACOR.
32. Ministerio de Salud de la Nación Guía Práctica Clínica Nacional sobre Prevención, Diagnóstico y Tratamiento de la Diabetes Mellitus Tipo 2 2009, Buenos Aires, Ministerio de Salud de la Nación.
33. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 12:352-837. UK Prospective Diabetes Study (UKPDS) Group.
34. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G. Glycemic durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. N Engl J Med 2006, 355:2427-2443. 10.1056/NEJMoa066224, 17145742.
35. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F, ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
36. Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591. 10.1056/NEJMoa0706245, 18256393.
37. Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vikek ME, Henderson WG, Huang GD. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139. 10.1056/NEJMoa0808431, 19092145.
38. Gagliardino JJ, Puppo R, Barragán H. Costos directos en diabetes. Estrategias para disminuir su repercusión socio económica. Rev. Soc. Argent. Diabetes 1989, 23:28.
39. Gagliardino JJ, Olivera EM. Aspectos socioeconómicos de la diabetes mellitus en la Argentina: diagnóstico epidemiológico. In Epidemiología y atención de la salud en la Argentina. Edited by Lemus JD 1993, OPS, AMA: Buenos Aires.
40. Gagliardino JJ, Olivera EM, Barragán H, Puppo RA. A simple economic evaluation model for selecting diabetes health care strategies. Diabet Medicine 1993, 10:351-354.
41. Gagliardino JJ, Williams R, Clark CM. Using hospitalization rates to track the economic costs and benefits of improved diabetes care in the Americas. A proposal for healthy policy makers. Diabetes Care 2000, 23:1844-1846. 10.2337/diacare.23.12.1844, 11128364.
42. Sereday M, Damiano M, Lapertosa S. Complicaciones crónicas en personas con diabetes mellitus tipo 2 de reciente diagnóstico. Endocrinol Nutr 2008, 55:64-68. 10.1016/S1575-0922(08)70638-7, 22964098.
43. Gagliardino JJ, González C, Caporale JE. The diabetes-related attitudes of health care professionals and persons with diabetes in Argentina. Revista Panamericana de Salud Pública/Pan American Journal of Public Health 2007, 22:304-307.
44. Álvarez A, Basile R, Bertaina V, Caporale J, Castelli M, Giménez L, Guntsche E, Litwak L, Lijteroff G, Masciottra F, Sinay I, Gagliardino JJ. Prevención primaria de Diabetes Tipo 2. Estado actual del conocimiento. Revista de la ALAD 2011, 1:17-28.
45. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725-731. 10.2337/diacare.26.3.725, 12610029.
46. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004, 27:727-733. 10.2337/diacare.27.3.727, 14988293.